These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6967924)

  • 1. Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice.
    Worthington M; Conliffe MA; Baron S
    J Infect Dis; 1980 Aug; 142(2):163-74. PubMed ID: 6967924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
    Rager-Zisman B; Allison AC
    J Immunol; 1976 Jan; 116(1):35-40. PubMed ID: 173758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of recovery from systemic vaccinia virus infection. I. The effects of cyclophosphamide.
    Worthington M; Rabson AS; Baron S
    J Exp Med; 1972 Aug; 136(2):277-90. PubMed ID: 5043413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.
    Oakes JE
    Infect Immun; 1975 Jul; 12(1):166-72. PubMed ID: 166926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes.
    Larsen HS; Russell RG; Rouse BT
    Infect Immun; 1983 Jul; 41(1):197-204. PubMed ID: 6305838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection.
    Oakes JE; Rosemond-Hornbeak H
    Infect Immun; 1978 Aug; 21(2):489-95. PubMed ID: 689732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation.
    Openshaw H; Asher LV; Wohlenberg C; Sekizawa T; Notkins AL
    J Gen Virol; 1979 Jul; 44(1):205-15. PubMed ID: 227991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice.
    Nagafuchi S; Oda H; Mori R; Taniguchi T
    J Gen Virol; 1979 Sep; 44(3):715-23. PubMed ID: 231089
    [No Abstract]   [Full Text] [Related]  

  • 9. Twp populations of T lymphocytes immune to the lymphocytic choriomeningitis virus.
    Volkert M; Marker O; Bro-Jorgensen K
    J Exp Med; 1974 May; 139(5):1329-43. PubMed ID: 4545164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSV-1 infection and immunity in immunosuppressed mice.
    Litwińska B; Sadowski W; Kańtoch M
    Acta Virol; 1987 Aug; 31(4):298-306. PubMed ID: 2892379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-specific IgM and IgG antibody production by B cells during herpes simplex virus type 2-induced immunosuppression as analysed by an immunospot assay.
    Nick S; Metzger B; Muller S; Falke D
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():1951-9. PubMed ID: 3037017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
    Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
    J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.
    Morrison LA; Zhu L; Thebeau LG
    J Virol; 2001 Feb; 75(3):1195-204. PubMed ID: 11152492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM; Stevens JG
    J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL; Lukig ML; Liew FY
    J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunosuppression on dengue virus infection in mice.
    Chaturvedi UC; Tandon P; Mathur A
    J Gen Virol; 1977 Sep; 36(3):449-58. PubMed ID: 562388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression and enhancement of humoral antibody formation by herpes simplex virus types 1 and 2.
    Nick S; Kampe P; Knoblich A; Metzger B; Falke D
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1015-24. PubMed ID: 3011967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction.
    Zawatzky R; Hilfenhaus J; Marcucci F; Kirchner H
    J Gen Virol; 1981 Mar; 53(Pt 1):31-8. PubMed ID: 6168735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
    Nash AA; Ashford NP
    Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies of hsv-infection of resistant and susceptible inbred strains of mice.
    Kirschner H; Kochen M; Hirt HM; Munk K
    Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):147-54. PubMed ID: 645175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.